Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin
Conclusions: Abnormalities in albumin and prealbumin levels are common among COVID-19 patients and hypoprealbuminemia independently predicts adverse outcome and should be carefully considered in clinical practice. Moreover, changes in liver-related biomarkers is not a salient feature of COVID-19.
Source: The Saudi Journal of Gastroenterology - Category: Gastroenterology Authors: Tao Li Ying Guo Xianghua Zhuang Laigang Huang Xingqian Zhang Fengtao Wei Baohua Yang Source Type: research
More News: Bilirubin | Coronavirus | COVID-19 | Gastroenterology | Laboratory Medicine | Liver | Middle East Health | Saudi Arabia Health | Study | Urology & Nephrology